Cargando…
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
BACKGROUND: Rotaviruses are the leading cause of severe acute gastroenteritis in children aged <5 years worldwide. A live attenuated human rotavirus vaccine, RIX4414 has been developed to reduce the global disease burden associated with rotavirus gastroenteritis. Serum anti-rotavirus immunoglobul...
Autores principales: | Cunliffe, Nigel, Zaman, Khalequ, Rodrigo, Carlos, Debrus, Serge, Benninghoff, Bernd, Pemmaraju Venkata, Suryakiran, Han, Htay-Htay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261882/ https://www.ncbi.nlm.nih.gov/pubmed/25433534 http://dx.doi.org/10.1186/s12887-014-0295-2 |
Ejemplares similares
-
Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016) -
Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015) -
Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012) -
Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013) -
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
por: Li, Rong-cheng, et al.
Publicado: (2014)